Edgewise Historical Income Statement

EWTX Stock  USD 32.20  0.12  0.37%   
Historical analysis of Edgewise Therapeutics income statement accounts such as Depreciation And Amortization of 1.8 M or Interest Expense of 4.9 M can show how well Edgewise Therapeutics performed in making a profits. Evaluating Edgewise Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Edgewise Therapeutics's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Edgewise Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Edgewise Therapeutics is a good buy for the upcoming year.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edgewise Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Edgewise Stock please use our How to Invest in Edgewise Therapeutics guide.

About Edgewise Income Statement Analysis

Edgewise Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Edgewise Therapeutics shareholders. The income statement also shows Edgewise investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Edgewise Therapeutics Income Statement Chart

At this time, Edgewise Therapeutics' Total Other Income Expense Net is fairly stable compared to the past year.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Edgewise Therapeutics. It is also known as Edgewise Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on Edgewise Therapeutics income statement and represents the costs associated with goods and services Edgewise Therapeutics provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Most accounts from Edgewise Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Edgewise Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edgewise Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Edgewise Stock please use our How to Invest in Edgewise Therapeutics guide.At this time, Edgewise Therapeutics' Total Other Income Expense Net is fairly stable compared to the past year.
 2021 2022 2023 2024 (projected)
Interest Income402K4.0M14.2M14.9M
Net Interest Income402K4.0M14.2M14.9M

Edgewise Therapeutics income statement Correlations

1.01.00.95-1.00.97-0.96-0.93-0.960.97-0.961.00.971.0-0.951.0-0.95-0.850.81-0.93
1.01.00.95-1.00.97-0.96-0.93-0.960.97-0.961.00.971.0-0.951.0-0.95-0.850.81-0.93
1.01.00.97-1.00.98-0.98-0.94-0.980.98-0.981.00.981.0-0.971.0-0.97-0.840.8-0.93
0.950.950.97-0.970.99-0.99-0.94-0.990.99-0.990.970.990.97-1.00.95-0.99-0.790.72-0.9
-1.0-1.0-1.0-0.97-0.980.980.950.98-0.980.98-1.0-0.98-1.00.97-0.990.970.85-0.820.91
0.970.970.980.99-0.98-1.0-0.92-1.01.0-1.00.981.00.98-1.00.97-1.0-0.770.71-0.92
-0.96-0.96-0.98-0.990.98-1.00.931.0-1.01.0-0.98-1.0-0.981.0-0.971.00.77-0.730.9
-0.93-0.93-0.94-0.940.95-0.920.930.93-0.920.93-0.94-0.92-0.940.92-0.910.910.94-0.890.8
-0.96-0.96-0.98-0.990.98-1.01.00.93-1.01.0-0.98-1.0-0.981.0-0.971.00.77-0.730.9
0.970.970.980.99-0.981.0-1.0-0.92-1.0-1.00.981.00.98-1.00.98-1.0-0.760.71-0.93
-0.96-0.96-0.98-0.990.98-1.01.00.931.0-1.0-0.98-1.0-0.981.0-0.971.00.77-0.730.9
1.01.01.00.97-1.00.98-0.98-0.94-0.980.98-0.980.981.0-0.971.0-0.97-0.840.8-0.93
0.970.970.980.99-0.981.0-1.0-0.92-1.01.0-1.00.980.98-1.00.97-1.0-0.770.71-0.92
1.01.01.00.97-1.00.98-0.98-0.94-0.980.98-0.981.00.98-0.971.0-0.97-0.840.8-0.93
-0.95-0.95-0.97-1.00.97-1.01.00.921.0-1.01.0-0.97-1.0-0.97-0.961.00.76-0.720.89
1.01.01.00.95-0.990.97-0.97-0.91-0.970.98-0.971.00.971.0-0.96-0.96-0.810.77-0.94
-0.95-0.95-0.97-0.990.97-1.01.00.911.0-1.01.0-0.97-1.0-0.971.0-0.960.74-0.70.9
-0.85-0.85-0.84-0.790.85-0.770.770.940.77-0.760.77-0.84-0.77-0.840.76-0.810.74-0.960.68
0.810.810.80.72-0.820.71-0.73-0.89-0.730.71-0.730.80.710.8-0.720.77-0.7-0.96-0.56
-0.93-0.93-0.93-0.90.91-0.920.90.80.9-0.930.9-0.93-0.92-0.930.89-0.940.90.68-0.56
Click cells to compare fundamentals

Edgewise Therapeutics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Edgewise Stock Analysis

When running Edgewise Therapeutics' price analysis, check to measure Edgewise Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edgewise Therapeutics is operating at the current time. Most of Edgewise Therapeutics' value examination focuses on studying past and present price action to predict the probability of Edgewise Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edgewise Therapeutics' price. Additionally, you may evaluate how the addition of Edgewise Therapeutics to your portfolios can decrease your overall portfolio volatility.